When Pathology Data Items Matter and When They Don't: A Urological Cancer Perspective
This review challenges the one-size-fits-all approach to histopathology reporting for urological cancers, arguing that the clinical significance of individual data items depends on the specific clinical scenario. The authors provide examples where standard minimum dataset items may be irrelevant, helping pathologists prioritize their limited resources for data elements that genuinely influence patient management.
The original study
Clinical utility of histopathology data: urological cancers.
- Authors
- Varma M, Williamson S
- Journal
- Journal of clinical pathology
- Type
- Journal Article, Review
- PMID
- 35853652
Original abstract
Cancer datasets recommend standardised reporting of histopathological data items with elements categorised as either core (required) or non-core (recommended), irrespective of the clinical scenario. However, the clinical significance of a data item in an individual case would depend on the clinicopathological setting as well as local management guidelines. A data item that is critical for patient management in one clinical scenario may be largely irrelevant in another patient. Pathologists must understand how their data are used in clinical practice so that they can focus their limited resources appropriately. We briefly review the use of histopathological data in the management of urological cancers, highlighting scenarios where a data item may be of limited clinical utility.